Accumetrics, Inc.’ VerifyNow System Receives Health Canada License for Clinical Use  
8/8/2012 10:26:28 AM

SAN DIEGO--(BUSINESS WIRE)--Accumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the VerifyNow System has been licensed for clinical use by Health Canada. The VerifyNow System is now available to hospitals and clinical laboratories in Canada to measure platelet reactivity in patients on antiplatelet medications including aspirin and P2Y12 inhibitors (clopidogrel).